401 related articles for article (PubMed ID: 30319638)
1. Chemokine Heterocomplexes and Cancer: A Novel Chapter to Be Written in Tumor Immunity.
D'Agostino G; Cecchinato V; Uguccioni M
Front Immunol; 2018; 9():2185. PubMed ID: 30319638
[TBL] [Abstract][Full Text] [Related]
2. β-Arrestin1 and β-Arrestin2 Are Required to Support the Activity of the CXCL12/HMGB1 Heterocomplex on CXCR4.
D'Agostino G; Artinger M; Locati M; Perez L; Legler DF; Bianchi ME; Rüegg C; Thelen M; Marchese A; Rocchi MBL; Cecchinato V; Uguccioni M
Front Immunol; 2020; 11():550824. PubMed ID: 33072091
[TBL] [Abstract][Full Text] [Related]
3. Redox-Mediated Mechanisms Fuel Monocyte Responses to CXCL12/HMGB1 in Active Rheumatoid Arthritis.
Cecchinato V; D'Agostino G; Raeli L; Nerviani A; Schiraldi M; Danelon G; Manzo A; Thelen M; Ciurea A; Bianchi ME; Rubartelli A; Pitzalis C; Uguccioni M
Front Immunol; 2018; 9():2118. PubMed ID: 30283452
[TBL] [Abstract][Full Text] [Related]
4. Chemokine receptor CXCR4: role in gastrointestinal cancer.
Lombardi L; Tavano F; Morelli F; Latiano TP; Di Sebastiano P; Maiello E
Crit Rev Oncol Hematol; 2013 Dec; 88(3):696-705. PubMed ID: 24120239
[TBL] [Abstract][Full Text] [Related]
5. Chemokine interaction with synergy-inducing molecules: fine tuning modulation of cell trafficking.
Cecchinato V; D'Agostino G; Raeli L; Uguccioni M
J Leukoc Biol; 2016 Jun; 99(6):851-5. PubMed ID: 26715684
[TBL] [Abstract][Full Text] [Related]
6. CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy.
Mousavi A
Immunol Lett; 2020 Jan; 217():91-115. PubMed ID: 31747563
[TBL] [Abstract][Full Text] [Related]
7. CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks.
Guo F; Wang Y; Liu J; Mok SC; Xue F; Zhang W
Oncogene; 2016 Feb; 35(7):816-26. PubMed ID: 25961926
[TBL] [Abstract][Full Text] [Related]
8. CXC chemokine ligand 12 (CXCL12) and its receptor CXCR4.
Nagasawa T
J Mol Med (Berl); 2014 May; 92(5):433-9. PubMed ID: 24722947
[TBL] [Abstract][Full Text] [Related]
9. CXCL12/CXCR4 axis in the microenvironment of solid tumors: A critical mediator of metastasis.
Mortezaee K
Life Sci; 2020 May; 249():117534. PubMed ID: 32156548
[TBL] [Abstract][Full Text] [Related]
10. Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy.
Morein D; Erlichman N; Ben-Baruch A
Front Immunol; 2020; 11():952. PubMed ID: 32582148
[TBL] [Abstract][Full Text] [Related]
11. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
Nazari A; Khorramdelazad H; Hassanshahi G
Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185
[TBL] [Abstract][Full Text] [Related]
12. Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells.
Venetz D; Ponzoni M; Schiraldi M; Ferreri AJ; Bertoni F; Doglioni C; Uguccioni M
Int J Cancer; 2010 Nov; 127(10):2300-12. PubMed ID: 20872671
[TBL] [Abstract][Full Text] [Related]
13. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.
Zhuo W; Jia L; Song N; Lu XA; Ding Y; Wang X; Song X; Fu Y; Luo Y
Clin Cancer Res; 2012 Oct; 18(19):5387-98. PubMed ID: 22932666
[TBL] [Abstract][Full Text] [Related]
14. Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response.
Koizumi K; Hojo S; Akashi T; Yasumoto K; Saiki I
Cancer Sci; 2007 Nov; 98(11):1652-8. PubMed ID: 17894551
[TBL] [Abstract][Full Text] [Related]
15. The role of CXCL12 in tumor microenvironment.
Meng W; Xue S; Chen Y
Gene; 2018 Jan; 641():105-110. PubMed ID: 29017963
[TBL] [Abstract][Full Text] [Related]
16. A review on CXCR4/CXCL12 axis in oncology: no place to hide.
Domanska UM; Kruizinga RC; Nagengast WB; Timmer-Bosscha H; Huls G; de Vries EG; Walenkamp AM
Eur J Cancer; 2013 Jan; 49(1):219-30. PubMed ID: 22683307
[TBL] [Abstract][Full Text] [Related]
17. The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow.
Shakir M; Tang D; Zeh HJ; Tang SW; Anderson CJ; Bahary N; Lotze MT
Pancreas; 2015 May; 44(4):528-34. PubMed ID: 25872129
[TBL] [Abstract][Full Text] [Related]
18. CXCL12 mediates immunosuppression in the lymphoma microenvironment after allogeneic transplantation of hematopoietic cells.
Dürr C; Pfeifer D; Claus R; Schmitt-Graeff A; Gerlach UV; Graeser R; Krüger S; Gerbitz A; Negrin RS; Finke J; Zeiser R
Cancer Res; 2010 Dec; 70(24):10170-81. PubMed ID: 21159639
[TBL] [Abstract][Full Text] [Related]
19. Molecular Pathways: Targeting the CXCR4-CXCL12 Axis--Untapped Potential in the Tumor Microenvironment.
Scala S
Clin Cancer Res; 2015 Oct; 21(19):4278-85. PubMed ID: 26199389
[TBL] [Abstract][Full Text] [Related]
20. Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study.
Giannice R; Erreni M; Allavena P; Buscaglia M; Tozzi R
Cytokine; 2013 Nov; 64(2):509-15. PubMed ID: 23985752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
